About the Journal
Therapeutic Radiology and Oncology
Aims and Scope
Therapeutic Radiology and Oncology (Ther Radiol Oncol; TRO; 2616-2768), launched in September 2017 and originated in 1994 and known in the field as the Blue Journal, publishes papers describing original research, case reports and clinical investigations related to radiation oncology. This includes clinical radiotherapy, radiobiology, chemotherapy, immunotherapy, hyperthermia, tumor biology, experimental therapeutics and clinical oncology. It also covers fields of medical physics, radiology, nursing care, education, technology, health information and health policy as it relates to radiology and oncology.
Advancements in therapeutic radiology and oncology have allowed physicians to better treat their patients with cooperation from multidisciplinary team members. The Journal TRO focuses on the most recent advances on a worldwide basis. It plays as a professional and comprehensive platform for readership relating to radiology and oncology.
The journal welcomes a wide range of submission types, including high-quality research, clinical trials reports, technique reports, review articles, editorial letter, etc. Articles will be solicited from recognized experts in these fields, while submissions for peer review will also be considered. The high quality of its content is assured by a rigorous review process, supervised by an international editorial board.
Information for Authors
TRO is a member of the International Committee of Medical Journal Editors (ICMJE) and follows the ICMJE recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journal and the Committee on Publication Ethics (COPE)'s guidelines.
Manuscripts submitted must be the original work of the author(s) and must not be published previously or under consideration for publication elsewhere.
Submission Turnaround Time
- In-house review: 1-3 weeks
- External peer review: 1-3 months
- Publication Ahead of Print: within 1 month after being accepted
- Formal publication: within 1-3 months after being accepted. Original Articles are listed as priority.
Open Access Statement
Therapeutic Radiology and Oncology is a peer reviewed, open access journal. All content of the journal is published under the Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). All articles published open access will be immediately and permanently free for all to read, download, copy and distribute as defined by the applied license.
Free access and usage
Permitted third party reuse is defined by the CC BY-NC-ND 4.0 license. This license allows users to copy and distribute the article, provided:
- this is not done for commercial purposes and further does not permit distribution of the Article if it is changed or edited in any way.
- the user gives appropriate credit (with a link to the formal publication through the relevant DOI) and provides a link to the license but not in an any way implying that the licensor is endorsing the user or the use of the work.
- no derivatives including remix, transform, or build upon the material was allowed for distribution.
For open access publishing, this journal uses an exclusive licensing agreement. Authors will transfer copyright to TRO, but will have the right to share their article in the same way permitted to third parties under the relevant user license, as well as certain scholarly usage rights.
For any inquiry/special circumstance on the copyright, commercial usage or adaptation of TRO articles, please contact: firstname.lastname@example.org
For reprint order, please contact: email@example.com
TRO is published by AME Publishing Company.
Address: Flat/RM C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong, China.
Updated on June 22, 2020